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Abstract
Background: Developing valid control groups that generate similar perceptions and expectations to experi-
mental complementary and alternative (CAM) treatments can be challenging. The perceived credibility of
treatment and outcome expectancy often contributes to positive clinical responses to CAM therapies, thereby
confounding efficacy data. As part of a clinical feasibility study, credibility and expectancy data were obtained
from subjects suffering from migraine who received either CranioSacral therapy (CST) or an attention-control,
sham, and low-strength magnet (LSSM) intervention.
Objective: The objective of this study was to evaluate whether the LSSM intervention generated similar levels of
subject credibility and expectancy compared to CST.
Design: This was a two-arm randomized controlled trial.
Subjects: Sixty-five (65) adults with moderate to severe migraine were the subjects of this study.
Interventions: After an 8-week baseline, subjects were randomized to eight weekly treatments of either CST
(n = 36) or LSSM (n = 29). The latter involved the use of a magnet-treatment protocol using inactive and low-
strength static magnets designed to mimic the CST protocol in terms of setting, visit timing, body positioning,
and therapist–subject interaction.
Outcome measures: A four-item, self-administered credibility/expectancy questionnaire, based on a validated
instrument, was completed after the first visit.
Results: Using a 0–9 rating scale, the mean score for perceived logicality of treatment was significantly less for
LSSM (5.03, standard deviation [SD] 2.34) compared to CST (6.64, SD 2.19). Subject confidence that migraine
would improve was greater for CST (5.94, SD 2.01) than for LSSM (4.9, SD 2.21), a difference that was not
statistically significant. Significantly more subjects receiving CST (6.08, SD 2.27) would confidently recommend
treatment to a friend than those receiving LSSM (4.69, SD 2.49).
Conclusions: Although LSSM did not achieve a comparable level of credibility and expectancy to the CST,
several design and implementation factors may have contributed to the disparity. Based on analysis of these
factors, the design and implementation of a future study may be improved.
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Amajor challenge in research on complementary andalternative medicine (CAM) is the development of a va-
lid control group with which to compare the intervention of
interest.1 In a well-designed study, the ideal control inter-
vention should closely resemble or mimic the intervention in
terms of procedure, treatment duration and frequency, and
therapist attention.2 In this way, researchers can assess and
control for placebo effects induced by a range of heteroge-
neous contextual, personal, and relational factors experienced
by the patient during treatment.3
Patient perceptions about treatment credibility and
expectancy of treatment outcome can play a large role in
persistent clinical improvement.3–7 For example, in a meta-
analysis of four randomized trials of acupuncture for chronic
pain, Linde et al. reported that more subjects with high ex-
pectations for improvement actually improved, compared
with those who had low expectations.8 In another systematic
review, positive subject expectations were consistently as-
sociated with better outcomes in 15 of 16 moderate to high-
quality clinical trials.4
Treatment credibility in a research context can be defined as
the extent to which subjects perceive experimental and con-
trol modalities to be rational and believable approaches to
their clinical problem.9 Expectancy is the belief that clinical
improvement will occur as a result of the intervention. Both
factors must be accounted for in studies of treatment efficacy,
usually by using a control intervention that is equally potent
in establishing treatment credibility and expectancy of im-
provement without affecting the biologic mechanism en-
gendered by the intervention under study.9,10
This study reports the credibility and expectation of ben-
efit of a novel attention-control procedure in a feasibility
study of CranioSacral therapy (CST) as adjunctive treatment
for migraine. The control procedure, involving a sham
magnet treatment protocol using inactive and low-strength
static magnets (LSSM), was designed to generate similar
levels of credibility and expectation of benefit among the




A feasibility study was undertaken for developing a ran-
domized, controlled trial to compare the effectiveness of CST
as adjunctive treatment for migraine compared to an atten-
tion-control intervention using LSSM. The study protocol has
been described elsewhere.11 CST was developed by Dr. John
Upledger, DO using the concept that abnormal cerebrospinal
fluid rhythms may follow birth injury or later traumas and
lead to a variety of neurophysiologic disturbances and
symptoms.11 CST, which purportedly releases tissue restric-
tions and eliminates stasis within the hydraulic system of the
brain and spinal cord, is increasingly sought by the public for
the relief of multiple conditions, including (1) headache, (2)
asthma, (3) arthritis, (4) insomnia, (5) cerebral palsy, (6) au-
tism, (7) memory disturbances, (8) whiplash injuries, and (9)
fibromyalgia.11
The proposed randomized trial for which this feasibility
study was undertaken would compare CST with a control
intervention, as measured by headache frequency and in-
tensity, and quality of life, (using the Headache Impact Test),
perception of benefit, migraine-related disability, general
health status (SF 36), and health care utilization.12–15 This
feasibility study was needed to develop, standardize, and
clarify treatment and control protocols, recruitment strate-
gies, and measurement and data-collection methods. The
development and credibility of treatment and control pro-
tocols in the management of moderate to severe migraine
headaches are reported here.
Development of treatment protocols. CST and LSSM
protocols required development, standardization, and evalu-
ation for their practical and efficient application in the even-
tual efficacy trial. A CST protocol was based on the clinical
evaluation and treatment system developed by the Upledger
Institute, comprising the intervention elements shown in Ta-
ble 1 and described previously.11,15 An LSSM protocol was
designed as an attention-control condition matching such
features of the CST protocol as frequency and duration of
visits, therapist–subject interaction, and treatment setting.
Table 1 compares the two treatment protocols. The complete
CST and LSSM protocols are described in the Appendix.
CST intervention. The CST assessment and intervention
was performed by 1 practicing therapist, who is also a
Table 1. Comparison of Treatment Protocols:
CranioSacral Therapy and Magnet Therapy
for Migraine
All subjects:
 Initial brief review of recent headache and general
symptoms
 Assessment of any adverse effects of prior treatment
 Blood pressure and pulse recorded before and after visit
 Headache severity recorded before and after visit
 Visual scan
 Subject remains supine for treatment
 Total clinic visit time = 45 minutes
CranioSacral therapy Magnet therapy
Evaluation of the CranioSacral
rhythm,a including
amplitude, quality, and rate








Lower respiratory Lower diaphragm
Thoracic inlet Upper thorax
(front and back)
Shoulders Upper thorax toward
shoulders
Neck Neck
Occiput Occiput (front and back)
Frontal/parietal bone lifts Head and feet
Sphenoid and mandible
mouth work
aThe CranioSacral rhythm is palpated by the practitioner (at the
feet) and assessed for rate, quality, and symmetry.
A normal rate is 8–12 cycles per minutes. A normal rhythm shows
a balanced vitality.
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registered nurse and licensed massage therapist, with ex-
tensive training and experience in CST. Only 1 therapist was
utilized at this phase of the research because it was believed
that a single individual, with training and close supervision
in this research setting, was more likely to achieve a stan-
dardized approach to each subject than could be achieved
by a variety of therapists, especially in a modality where
weak clinical reliability between practitioners has been
reported.16,17
Control intervention. One important question was whe-
ther CST (a manual technique) could be effectively mimicked
as a sham procedure, or whether a different but appropriate
complementary modality could be used as an effective con-
trol procedure. Two options were considered.
Option 1: Sham CST. Sham maneuvers have been widely
used as controls in osteopathic medicine and chiropractic
research.9,18,19 An ideal control method for CST, which con-
sists of assessment and treatment using gentle muscle pal-
pation and mobilization techniques, would be to exactly
replicate the CST protocol without producing any treatment
effect. Sham CST would have to be given either by an expert
CST practitioner or by a specially trained massage therapist.
Furthermore, the CST sham procedure would have to last a
comparable amount of time (i.e., 45 minutes) as the CST
treatment and be standardized and replicable at each visit.
Ultimately, it was concluded that it was unlikely a sham
manual procedure could be created that would closely mimic
CST without producing an unintended biologic effect.
Option 2: LSSM. Inert and active magnets were provided
courtesy of American Health Services Magnets, Palatine, IL.
Instead of a sham CST arm, it was decided to develop a
control protocol that could generate similar elements of
placebo effects. These elements included (1) a similar pro-
cedural treatment sequence using gentle physical contact
directed at the same anatomical areas; and (2) replication of
the CST visit context using the same therapist in the same
location (i.e., the therapist’s treatment room in an integrative
outpatient clinic) as that used for subjects receiving the true
CST intervention. It was posited that magnet therapy, widely
used by the public for pain syndromes, could generate
equivalent therapeutic credibility and outcome expectations
if delivered in the same context and by the same therapist as
in the CST arm. Static magnet therapy is a popular and near-
zero risk modality that, at low to moderate intensities (300–
800 + G), has been shown to affect nerve cells and increase
local tissue blood flow and oxygenation when magnets are in
direct contact with the skin.20–22
The CST therapist was trained in the LSSM protocol for
this study. To ensure that the LSSM control protocol had no
human biologic effects, the protocol called for the therapist to
place six identical inert ceramic magnets (1.6 cm in diameter
and 0.4-cm thick) and six weakly active bipolar magnets
(300–500 G) at intervals around the perimeter of the exami-
nation table on which the control subject was resting. Both
the active and inert magnets were placed at distances of 3 to
5 inches from the subject’s body, with the active magnets
positioned further than the inert magnets. (The inverse
square law, as applied to electromagnetism, states that
doubling the distance between subject and magnet reduces
field intensity by 75%.) At each session, the therapist used a
magnetometer to confirm that for the active magnets the field
intensity at the subject’s skin was close to zero (no more than
30–80 G) (DC Magnetometer Model 1, with a resolution of
0.1 G, manufactured by AlphaLab, Inc., Salt Lake City, UT).
The magnetometer was also used by the therapist to display
a positive reading when placed up against an active magnet
in order to enhance the believability of the magnet inter-
vention for curious subjects.
In order to replicate more exactly the sequence and ana-
tomical location of the CST protocol, three inert magnets
(rectangular 2 · 5 cm by 0.4-cm thick) contained inside a cloth
pad were applied by the therapist to several locations on the
center of the body (over clothes, from the lower part of the
abdomen to the head). This cloth pad was applied to the
same locations at the same time intervals as in the CST
procedure (Table 2). In contrast to the CST, no soft-tissue
pressure or motion was exerted by the pad, and there was no
direct touching of the subject by the therapist (other than
assistance in getting on and off the table). The therapist re-
mained attentive and in the room with the subject during the
entire procedure, either sitting or moving about the room to
apply the magnets and monitor their strength. In both the
CST and LSSM protocols, conversation between subject and
therapist was driven by subjects’ preferences.
In the process of informed consent, the study volunteers
were given a description of CST and magnet therapy and
their potential usefulness for improving migraine headaches.
At the beginning of the first treatment, the therapist de-
scribed, per scripted protocol, how CST and magnets might
produce a biologic effect, referring to available articles and
pamphlets describing the benefits of CST and magnet
Table 2. Characteristics of the Study Sample:








Mean (range) Mean (range)
Age (years) 42.9 (12–71) 41.2 (19–72)
Education (years of school) 16.7 (7–28) 16.9 (12–20)
Average number of monthly
headache days,
pretreatmentb
13.4 (5–28) 13.6 (6–27)
N (%) N (%)
Female 33 (91.7) 32 (97.0)
White 28 (77.8) 29 (87.9)
Living with partner 24 (66.7) 23 (69.7)
Employed 24 (66.7) 29 (87.9)
Household income
< $20,000 6 (16.7) 1 (3.03)
$20,000–59,999 12 (33.3) 8 (24.2)
$60,000–99,999 4 (11.1) 8 (24.2)
> $100,000 13 (36.1) 10 (30.3)
Missing 1 6
aReported N reflects the 69 randomized subjects.
bThe mean number of headache days was calculated from the
mean number of headaches in the 2 months prior to the intervention
and the mean number of days reported in the diaries.
CREDIBILITY OF CONTROL GROUP FOR CRANIOSACRAL THERAPY INTERVENTION 713
therapy, available in her treatment room (see the Appendix
for therapist’s script for CST and LSSM conditions).
Reliability of the therapist
The therapist was a key participant in the initial develop-
ment of both CST and magnet protocols (subject communi-
cation, technique, and sequencing) and was subsequently
trained in the procedures over several weeks. Particular em-
phasis was given to standardizing communication, move-
ment, and contact with the subject to eliminate bias; the first,
third, fifth, and seventh treatment sessions with each subject
were videotaped and evaluated by research staff for com-
munication or physical bias toward one or other of the
protocols.
Assessment of treatment credibility and expectancy
The credibility of the protocols and the expectancy of
improvement for each subject were assessed by their com-
pletion of a commonly used and adapted self-report instru-
ment that had been originally developed by Borkovec and
Nau.23,24 Borkovec and Nau used a 0- to 9-point scale for
five questions to which the subject could mark his/her de-
gree of confidence in treatment rationale and expected out-
come, regarding psychologic interventions for a specific
psychologic problem: anxiety in public speaking. Others
have successfully modified this scale, adapting it for use
with other illnesses and interventions.25,26 The first three of
the original five items in Borkovec and Nau’s instrument
were adapted: (1) How logical does this type of treatment
seem to you? (2) How confident would you be that this
treatment would be successful? and (3) How confident
would you be in recommending this treatment to a friend?
An attempt was made to adapt the final two questions of
Borkovec and Nau’s original questionnaire, which deal with
hypothetical situations involving anxiety23 (i.e., ‘‘If you were
extremely anxious in speech situations, would you be will-
ing to undergo such treatment?’’ and ‘‘How successful do
you feel this treatment would be in decreasing a different
fear, for example, strong anxiety about taking tests?’’). In-
stead, a question was added regarding the subject’s confi-
dence in the therapist’s competence—a factor closely linked
to treatment credibility. The resulting four-item question-
naire was completed by each subject at the beginning of the
second treatment visit and was placed in an envelope for
retrieval by the research staff. The four questions were
worded as follows:
1. How logical does this type of therapy seem to you for
helping people treat or prevent their headache? (Not
logical [0]—very logical [9])
2. How confident are you that this treatment will be suc-
cessful in reducing your headache symptoms if you
were to have approximately eight such treatments over
the course of 2 months? (Not at all confident [0]—very
confident [9])
3. How confident would you be in recommending this
treatment to a friend who has a problem with head-
aches? (Not at all confident [0]—very confident [9])
4. How competent do you consider the therapist who
gave you treatment to be? (Not at all competent [0]—very
competent [9])
Results
Sixty-five (65) of 69 randomized subjects completed the
credibility/expectancy instrument. Subjects were predomi-
nantly white, female, and college educated. The mean age in
the CST group was 42.9 and that in the LSSM group was 41;
ages ranged from 12 to 71 years in the CST group (Table 2).
Using a 0–9 rating scale, the mean score for perceived
logicality of treatment (question 1) was significantly less for
LSSM (5.03, SD 2.34) compared to the CST group (6.64, SD
2.19), p = 0.005. Although subjects’ confidence that migraine
would improve (question 2) was greater for CST (5.94, SD
2.01) than for LSSM (4.9, SD 2.21), this difference was not
statistically significant ( p = 0.06). In response to question 3,
significantly more subjects receiving CST (6.08, SD 2.27)
would confidently recommend treatment to a friend than
those receiving LSSM (4.69, SD 2.49), p = 0.03 (Table 3). On
the other hand, subjects from both groups were equally and
strongly positive about the competence of the therapist
(question 4), with no between-group differences (8.41, SD
0.95 versus 8.31, SD 1.09), p = 0.815 on the Wilcoxon sum
rank test. The withdrawal/dropout rate was very similar
between the groups (11.1% for CST and 15.2% for LSSM
[p = 0.62]).
Upon examining individual responses, it was noted that
scores for some subjects—1 in the CST group and 4 in the
magnet group—differed dramatically from the norm. These
individuals had responded with a 0 or 1 for every item, ex-
cept confidence in the therapist, indicating a complete lack of
confidence in the proposed treatment. When the data from
these five outliers were removed, the only significant dif-
ference remaining between LSSM and CST on any of the
items was in logicalness of therapy (Table 4).
Discussion
Study participants in the CST and LSSM groups re-
sponded significantly differently in terms of treatment
credibility and expectancy of benefit. Removal from the
analysis of outlier data from those subjects in either group
who perceived that their treatment had no credibility and
expressed no confidence in it (1 in the CST group and 4 in the
LSSM group) revealed that the only remaining significant
difference between LSSM and CST was in the logicality of
the procedure.
Table 3. Comparison of Mean Credibility Scores








Survey items Mean (SD) Mean (SD) p-Valuea
1. Therapy is logical 5.03 (2.34) 6.64 (2.19) 0.005
2. Confident in success 4.90 (2.21) 5.94 (2.01) 0.062
3. Willing to recommend
to a friend
4.69 (2.49) 6.08 (2.27) 0.029
4. Therapist is competent 8.41 (0.95) 8.31 (1.09) 0.815
aBased on Wilcoxon two-sample, two-sided test.
SD, standard deviation.
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Since the credibility/expectancy scores diverged signifi-
cantly between the CST and LSSM groups, and since beliefs
about logicality and expectation of benefit have been known
to influence outcomes, it was important to explore and iden-
tify possible factors in the management and implementation
of this feasibility study that may have contributed to differ-
ences in credibility scores between the CST and LSSM treat-
ments, as follows: (1) Was there any bias in recruiting subjects
and explaining the protocols? (2) Was the design or execution
of the LSSM protocol less than optimal? (3) Was the assess-
ment of credibility flawed in terms of validity or timing?23,27
(4) How credible were either of the interventions?
These questions are addressed below.
1. Possible bias in recruiting subjects and explaining the pro-
tocols. At recruitment, and on the first treatment visit,
subjects may have received inadequate information or
may not have clearly understood the rationale of one or
both interventions. The degree of understanding was
assessed verbally by the therapist at the recruitment
and first treatment visit but not measured quantita-
tively. Horvath reported that treatment expectancy was
closely linked to the amount and quality of information
presented to subjects as part of explaining therapeutic
rationales.28 A communication disparity between CST
and LSSM groups might have adversely affected the
credibility score of LSSM. In a future study, this possi-
ble disparity could be remedied by applying a survey
instrument to test understanding and knowledge.
In retrospect, there were subtle biases toward pro-
moting CST in the recruitment and consent materials,
such as describing the therapist as highly experienced in
CST but not giving an equivalent statement for her
skills with LSSM; and placing CST description text first
in the consent and informational materials, possibly
emphasizing its relative importance. Also, all subjects
were treated in the CST therapist’s office, which was
located in a holistic health treatment facility that offered
CST. Flyers available in the waiting area regarding CST,
while not related to the study, may have introduced
bias in the participants, since information about LSSM
was available only in the treatment room.29
2. LSSM protocol: Possible flaws and solutions. Several fac-
tors may have limited the credibility of the LSSM
protocol and could be improved in a subsequent study:
(1) The magnets were located in Velcro pockets, created
by a local seamstress, and may not have had the same
cachet as the use of commercially marketed magnet
products. (2) The therapist, an expert in CST, had no
prior experience with magnet therapy and may have
been subconsciously biased against giving this form of
treatment. Thus, hiring a separate therapist who used
magnets regularly in a CAM practice might have added
to the credibility of the intervention. (3) Also, blinding
the therapist to the relative activity of the magnets
might have increased her own belief in magnet capa-
bility, and her belief could have been passed on to
subjects. (4) Moreover, the therapist reported that some
subjects mentioned to her that they had been especially
attracted to the study by the opportunity to receive CST
and were disappointed when they found that they were
assigned to the LSSM group.
3. Possible flaws in use of credibility instrument. The use or
timing of the credibility instrument may not have been
optimal. (1) The credibility instrument was modified, as
was done in previous studies, but was not revalidated.
It is unclear whether the modified instrument remains
entirely valid. It has become common practice to ad-
minister the credibility instrument after the first expo-
sure to the treatment. Would other timing be more
useful? Or should the expectancy question have been
asked immediately after randomization? (2) Should the
credibility questionnaire have been re-administered at
the end of the treatment period? (3) From the data and
careful review of the study design and trajectory, sev-
eral problems were identified that probably influenced
the credibility and expectancy scores.
The time point during the study at which these beliefs
are measured may be important. Martin et al. reported that
although valid expectancies of treatment can often be de-
rived from patient perceptions before therapy begins, these
beliefs can sometimes change quickly after the first treat-
ment experience.28,30 In the current study, the credibility
data were obtained just before the second treatment, in
keeping with current thinking about appropriate timing of
expectancy measures; but timing can affect response va-
lidity. For example, although question 3 in the credibility
instrument asks the subject to score his/her confidence in
recommending the modality to a friend, in this study the
question was asked after only one treatment session.
Hence, subject response would have been more likely the
result of guesswork than derived from a thorough expe-
rience with the intervention. Currently, there is no general
agreement in the literature on when and how often credi-
bility and expectancy measures should be undertaken.
Although data from the credibility surveys showed
that LSSM therapy was less credible than CST with
diminished expectancy of improved outcome, there are
some concerns that the instrument may not be mea-
suring what has been claimed for it.23,28 Although la-
beled a ‘‘credibility’’ instrument, the second and third
questions in this assessment tool deal with treatment
expectancy. Given the fact that, over time, Borkovec
and Nau’s instrument has been modified and adapted
in terms of questions and type of scale with little further
validation, it would be useful to re-assess the constructs
Table 4. Comparison of Mean Credibility
Scores by Treatment Type: CranioSacral
and Magnet Therapy for Migraine with Removal







Survey items Mean (SD) Mean (SD) p-Valuea
1. Therapy is logical 5.54 (1.88) 7.03 (1.51) 0.004
2. Confident in success 5.56 (1.53) 6.11 (1.76) 0.200
3. Willing to recommend
to a friend
5.36 (1.96) 6.25 (2.05) 0.095
4. Therapist is competent 8.44 (0.96) 8.40 (0.95) 0.815
aBased on Wilcoxon two-sample, two-sided test.
SD, standard deviation.
CREDIBILITY OF CONTROL GROUP FOR CRANIOSACRAL THERAPY INTERVENTION 715
of the instrument with particular reference to comple-
mentary therapies.
It is interesting that the dropout rate during treatment
was not significantly different between the groups. A
high subject dropout rate would have been expected for
a CAM therapy that lacked credibility and generated low
expectations of success. Second, some validation of the
LSSM control in terms of producing similar expectancy
and placebo effects to CST comes from the high ratings of
the procedural competence of the therapist by both study
groups. Rating the therapist highly would not fit easily
with the perception that they were receiving illogical
treatment and had low expectations of improvement.
4. Credibility of either intervention. Apart from the high
positive scores regarding the competence of the thera-
pist, overall expectancy scores in this study were only in
the moderate range of the scale. Goossens et al. re-
ported similar findings of moderate expectancy scores
in their study of behavioral interventions in chronic
pain,28 suggesting that patients suffering from a chronic
problem might well have low expectations and credi-
bility because of previous disappointments. It is possi-
ble that many migraine subjects in this study fell into
this chronic symptom category. However, this result
may have been influenced by the fact that the ques-
tionnaire was given to the subject by the therapist just
before the second intervention session.
Second, the often lackluster medical experience of
migraine sufferers might produce a degree of skepti-
cism and reticence toward the claims of benefit for ei-
ther CST or LSSM made during recruitment. Thus, it
might be useful in the future to probe responses to such
credibility surveys in more detail to explore why sub-
jects do, or do not, believe in the potential efficacy of
any therapies they are receiving.
Conclusions
While several design and implementation factors may
have contributed to the observed differences, LSSM did not
achieve comparable levels of credibility and expectancy to
CST. Valuable information has been gained that will assist
with interpretation of outcomes, for which analysis is under
way, and that will improve the design and execution of a
future clinical trial. First, the authors have developed and
tested a popular CAM therapeutic modality, CST, with a
population of patients with migraine headache and found
that it is at least moderately credible as an intervention.
Second, the authors have developed and tested the feasibility
of using a novel attention-control intervention, LSSM, gain-
ing important information about possible improvements in
design and implementation of future studies. Finally, an
improved attention-control strategy could offer a viable at-
tention-control methodology for research on CAM inter-
ventions in which establishing a rigorously mimicked control
group is required but problematic.
Future Directions
Future research will focus on incorporating changes in
design of the LSSM intervention, based on the above find-
ings. If credibility/expectancy equivalence is established, the
authors will proceed to test the effectiveness of CST in mi-
graine using a larger study population. In addition, it is
planned to revisit the construct and validity of measuring
credibility as it applies to CAM interventions.
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Appendix: Protocol for CranioSacral Therapy
[Therapist script is in italics]
1. Explain the rationale for CranioSacral therapy, and then help the subject settle comfortably on the massage table.
Let me tell you how the CranioSacral treatment will be organized today. First of all, I want you to know that CranioSacral therapy
has few adverse effects; you may feel a bit sleepy after your treatment and some people notice vivid dreams. As you may know,
CranioSacral therapy is already widely used for treatment, although there hasn’t been much research in conventional medicine.
That’s why we are doing this study. It is thought that CranioSacral therapy helps people with headaches by normalizing the rhythm
of fluid in the nervous system.
Are you ready to go ahead now?
Visit Tasks
1 Explain protocol; VIDEOTAPE; treat; document.
2 Give patient credibility questionnaire; treat; document.
3 VIDEOTAPE; treat; document.
4 Treat; document.
5 VIDEOTAPE; treat; document.
6 Treat; document.
7 VIDEOTAPE; treat; document.
8 Ask subject to continue diary; treat; document.
Headache history:
Duration of headaches: _________years
History of physical trauma: __________________________________________________________________________________
Location of headaches: ______________________________________________________________________________________
Type of headache: __________________________________________________________________________________________
If you feel like talking during the therapy, you may do so; it does not interfere with the therapy. It is also fine if you do
not talk or even if you fall sleep.
CranioSacral session 1 Date: _____________ Subject ID: _______________
Headache intensity prior to therapy:
,0 None ,1 Mild ,2 Moderate ,3 Severe
BP: ________/__________ P:____________
Action Results
Visual scan , Normal , Abnormal:
CS rhythm, rate, and , Normal , Abnormal:
symmetry
Feet/ankles/knees
Assessment , Assessed , NA
RTM , Not treated , Simple , Complex:
Sacrum





RTM , Not treated , Simple , Complex:
Upper thoracic
Assessment , Assessed , NA
RTM , Not treated , Simple , Complex:
Shoulders
Assessment , Assessed , NA
RTM , Not treated , Simple , Complex:
Neck
Assessment , Assessed , NA
ROM , Normal , Restricted:
RTM , Not treated , Simple , Complex:
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Hyoid
, Treated , NA
Occiput
Assessment , Assessed , NA
ROM , Normal , Abnormal:
Treatment , None , Simple , Complex:
Parietal
Parietal lift , Not treated , Simple , Complex:
Frontal





, Torsion , Left , Right
, Side bend , Left , Right
, Lateral strain , Left , Right
, Vertical strain , Superior , Inferior







Assessment , Assessed , NA
, Compression–decompression
Mouth work
1. Maxilla , Assessed , NA
, Flexion–extension , with sphenoid
Torsion , Left , Right
Shear , Left , Right
, Impaction–compression
2. Vomer , Not treated , Torsion: , Shear:
3. Nasal bone , Not treated ,
4. Palatines , Not treated ,
5. Teeth , Not treated , Quadrant:
6. Zygoma , Not treated ,
Rocking the falx , Not treated , Simple , Complex:
Dural tube , Rock , Glide
CV4 ,
Summary assessment
Restrictions , Mild , Moderate , Severe
Percent improvement __________ %
Comments:
Headache intensity at end of therapy:
,0 None ,1 Mild ,2 Moderate ,3 Severe
BP: ________/__________ P:____________
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PROTOCOL FOR MAGNET THERAPY
[Therapist script is in italics]
1. Explain the rationale for CranioSacral therapy, and then help the subject settle comfortably on the massage table.
2. Explain how the magnets are set up on the table, and that pads containing magnets will be applied for 5–10-minute
periods to different parts of the body and the head.
3. Show subject the small pads containing the magnets and explain how they will be used. Let subject know that you will
check the magnetic fields twice during the session.
4. Ask subject to lie down comfortably on the table. If they need to get up and stretch from time to time, they can do this.
5. Attach magnets according to the diagram, using Velcro to the sides of the sheet lying on the table while patient watches.
6. Apply the stretch wraps with magnetic pads over washable flannel covers to the patient’s body in sequence as follows:
(a) Around both ankles (5 minutes)
(b) Around both knees or thighs (5 minutes)
(c) Under sacrum and over pelvis (5 minutes)
(d) Over anterior lower rib cage and over upper rib cage (5 minutes)
(e) Around both shoulders (5 minutes)
(f) Neck and occiput (5 minutes)
(g) Forehead and feet (5 minutes)
Let me tell you how the magnet treatment will be organized today. First of all, I want you to know that magnet therapy produces no
adverse effects and the magnets are of low strength (300–800 G). As you may know, magnets are already widely used for treatment,
although there hasn’t been much research in conventional medicine. That’s why we are doing this study.
Their health benefits come from the fact that magnets have been shown to affect local blood vessels and improve local blood flow and
they increase oxygenation and cell metabolism. That’s what we are hoping will help the migraine headache.
Would you like to look at a magnet? This is what they look like before we sew them into the material. (Show participant
an active loose magnet and let him or her handle). I will be placing magnets around you on the table to create a magnetic field.
This Gaussmeter lets me check the field.
In addition to the magnets I place around the table, I will be using these pads that contain several small magnets on different parts of
your body, starting at your ankles, going up the body and ending with your head. I will change the positions about every 5 minutes.
If you feel like talking during the therapy, you may do so; it does not interfere with the therapy. It is also fine if you do not
talk or even if you fall sleep.
Are you ready to go ahead now?
Reminders:
1. Treatment duration: 45 minutes
2. Background magnets should be attached to sheet with Velcro
3. Move magnet pads around body every 5 minutes
4. No adverse effects
5. Do you have any questions about the magnets?















1 Explain protocol; videotape, treat; document.
2 Give patient credibility questionnaire; treat; document.
3 Videotape; treat; document.
4 Treat; document.
5 Videotape; treat; document.
6 Treat; document.
7 Videotape; treat; document.
8 Ask subject to continue diary; treat; document.
Headache history:
Duration of headaches: _________years
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Magnet session 1 Date: _____________
Subject ID: _______________
Headache intensity prior to therapy:
,0 None ,1 Mild ,2 Moderate ,3 Severe
BP: ________/__________ P:____________
Action Results
Visual scan , Normal , Abnormal:
Magnets attached to sheet , 1 , 2 , 3 , 4 , 5 , 6
, 7 , 8 , 9 , 10 , 11 , 12
CS rhythm: feet
Assessment
Rate , Normal , < 8 , > 12
Magnet applications
Around both ankles , 5 minutes , Other:
Intensity of magnets at ankles , None , < 300 , 300–500 , > 500
Around both knees or thighs , 5 minutes , Other:
Intensity of magnets at knees , None , < 300 , 300–500 , > 500
Under sacrum and over pelvis , 5 minutes , Other:
Intensity of magnets at hips , None , < 300 , 300–500 , > 500
Lower and upper rib cage , 5 minutes , Other:
Around both shoulders , 5 minutes , Other:
Intensity of magnets at shoulders , None , < 300 , 300–500 , > 500
Neck and occiput , 5 minutes , Other:
Intensity of magnets above head , None , < 300 , 300–500 , > 500
Forehead and feet , 5 minutes , Other:
Intensity of magnets at feet , None , < 300 , 300–500 , > 500
Summary assessment
Comments:
Headache intensity at end of therapy:
,0 None ,1 Mild ,2 Moderate ,3 Severe
BP: ________/__________ P:____________
BP, blood pressure; P, pulse; CS, CranioSacral; NA, not applicable; RTM, rhythm; ROM, range of motion.
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